A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis

Clinical trial NCT06865417 · RECRUITING

Trial details

NCT number: NCT06865417
Sponsor: Alfasigma S.p.A.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2025-09-29
Primary completion: 2028-06-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.